Detalhe da pesquisa
1.
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cochrane Database Syst Rev
; 1: CD014908, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622724
2.
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cochrane Database Syst Rev
; 5: CD014908, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184292
3.
Abortion Care Beyond 13 Weeks' Gestation: A Global Perspective.
Clin Obstet Gynecol
; 64(3): 460-474, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323228
4.
Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice.
Am J Obstet Gynecol
; 223(3): 372-378, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32522513
5.
Assessing providers' vaccination behaviors during routine immunization in India.
J Trop Pediatr
; 61(4): 244-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25833096
6.
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception: a Cochrane systematic review.
BMJ Sex Reprod Health
; 49(3): 201-209, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882324
7.
Association of State Funding for Comprehensive Reproductive Health Care With Use of Contraception Among Latina Patients and Non-Latina Patients in Oregon.
JAMA Health Forum
; 4(7): e232144, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505490
8.
Global Preconception and Contraception Care: Using a Life-Course Approach to Improve Health Outcomes in Lower-Resource Settings.
Obstet Gynecol Clin North Am
; 49(4): 647-663, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328673
9.
Acceptability and Barriers to Use of the ASMAN Provider-Facing Electronic Platform for Peripartum Care in Public Facilities in Madhya Pradesh and Rajasthan, India: A Qualitative Study Using the Technology Acceptance Model-3.
Int J Environ Res Public Health
; 17(22)2020 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33187163
10.
Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial.
Contraception
; 100(5): 391-396, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31226322